The Herbold Computational Biology Program of the Fred Hutchinson Cancer Center in Seattle, Washington invites applications for the Mahan postdoctoral fellowship. The fellowship will provide an exceptional individual with an early start on their career as an independent scientist by providing a 21-month stipend to pursue their proposed research project in the laboratory of a Fred Hutch Computational Biologist mentor.
Faculty of any discipline or rank from the Fred Hutch, UW, or any other institute may be proposed as co-mentors. The project must be focused on a topic of biological interest, must involve a computational or mathematical component, and may include an experimental component. A laboratory trained scientist may satisfy the computational and mathematical requirement by including a training component in their proposal. Computationally strong candidates may include a laboratory training component as well. The research direction should reflect the interests and ideas of the applicant, although the final research proposal may be jointly designed; see Additional Information for more details on the application process and for a list of potential mentors.
Fred Hutchinson Cancer Center is an independent, nonprofit, unified adult cancer care and research center that is clinically integrated with UW Medicine, a world leader in clinical care, research and learning. The first National Cancer Institute-designated cancer center in the Pacific Northwest, Fred Hutch's global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy, and COVID-19 vaccines has confirmed our reputation as one of the world's leading cancer, infectious disease and biomedical research centers. Based in Seattle, Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy, and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures for the world's deadliest diseases and make life beyond cancer a reality.
At Fred Hutch, we believe that the innovation, collaboration, and rigor that result from diversity and inclusion are critical to our mission of eliminating cancer and related diseases. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an antiracist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, antiracism, and inclusion.
Please direct all questions to Ruby Mae San Pedro, Computational Biology Research Administrator.
Ph.D. must have been awarded after June 2020 in a computational, quantitative or biological discipline.
Ph.D. must be awarded prior to the start of the fellowship.
Applicants who have held faculty, staff scientist, or research associate positions are not eligible.
Fred Hutch Internal applicants – Start date at Fred Hutch must be within 12 months of the pre-application deadline
Key Application Dates
Pre-application Deadline: December 9, 2022
Notification to proceed with Full Proposals: January 3, 2023
Full Proposal Deadline: February 7, 2023
Notification of Final Selection: March 1, 2023
Earliest Start Date: July 3, 2023
Please submit the following materials/information through the Interfolio application portal:
1-page (maximum) Proposed Research Statement *not including references
1 Letter of Recommendation
1-page (maximum) diversity, equity, and inclusion statement
(optional) Select a primary mentor through the Interfolio application portal
Pre-application materials are due December 9, 2022
Final Application Phase (if invited)
Upon invitation by the review committee, please submit the following materials/information through the Interfolio application portal:
3-5 page single-spaced, font size 11pt (not including references)
may be co-written with the proposed mentor
2 additional letters of recommendation
Full proposals are due February 7, 2023
The start date of the fellowship is flexible but should start within 1 year of the award.
Applicants are encouraged, but not required to contact a potential mentor (see list below).
Mentors may be contacted to get a statement of interest in the area, to assess the lab resources to see if they are adequate, or other general questions. However, the research idea(s) in the research statement need to be substantively those of the candidate.
Candidates who are invited to submit a full proposal may work more closely with the mentor at that time.
Fred Hutch is proud to be an Equal Employment Opportunity (EEO) and Vietnam Era Veterans Readjustment Assistance Act (VEVRAA) Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability (physical or mental), marital or veteran status, genetic information, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to our Employee Services Center at firstname.lastname@example.org or by calling 206-667-4700.
At Fred Hutchinson Cancer Research Center, teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Researchers are discovering new ways to detect cancers earlier, improve treatments, and learn how to prevent cancers from growing. Although Fred Hutchinson opened its doors in 1975, its history began about 20 years before that. In 1962 Fred Hutchinson envisioned a center devoted to studying cancer, a disease that took his brother’s life. Today Fred Hutchinson is contributing to the next waves of breakthrough treatments and prevention strategies. Fred Hutchinson collaborates with the Seattle Cancer Alliance, the National Cancer Institute, and the University of Washington.